These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2957611)

  • 41. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons.
    Aylward EH; Brandt J; Codori AM; Mangus RS; Barta PE; Harris GJ
    Neurology; 1994 May; 44(5):823-8. PubMed ID: 8190282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clustering of multiallele DNA markers near the Huntington's disease gene.
    MacDonald ME; Cheng SV; Zimmer M; Haines JL; Poustka A; Allitto B; Smith B; Whaley WL; Romano DM; Jagadeesh J
    J Clin Invest; 1989 Sep; 84(3):1013-6. PubMed ID: 2569477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved predictive testing for Huntington disease by using three linked DNA markers.
    Hayden MR; Robbins C; Allard D; Haines J; Fox S; Wasmuth J; Fahy M; Bloch M
    Am J Hum Genet; 1988 Nov; 43(5):689-94. PubMed ID: 2973229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain imaging and cognitive dysfunctions in Huntington's disease.
    Montoya A; Price BH; Menear M; Lepage M
    J Psychiatry Neurosci; 2006 Jan; 31(1):21-9. PubMed ID: 16496032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene.
    Squitieri F; Esmaeilzadeh M; Ciarmiello A; Jankovic J
    Mov Disord; 2011 Apr; 26(5):925-7. PubMed ID: 21370274
    [No Abstract]   [Full Text] [Related]  

  • 46. Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography.
    Künig G; Leenders KL; Sanchez-Pernaute R; Antonini A; Vontobel P; Verhagen A; Günther I
    Ann Neurol; 2000 May; 47(5):644-8. PubMed ID: 10805336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New mutation to Huntington's disease.
    Wolff G; Deuschl G; Wienker TF; Hummel K; Bender K; Lücking CH; Schumacher M; Hammer J; Oepen G
    J Med Genet; 1989 Jan; 26(1):18-27. PubMed ID: 2563774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cortical glucose metabolism in Huntington's disease.
    Martin WR; Clark C; Ammann W; Stoessl AJ; Shtybel W; Hayden MR
    Neurology; 1992 Jan; 42(1):223-9. PubMed ID: 1531155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.
    Borovecki F; Lovrecic L; Zhou J; Jeong H; Then F; Rosas HD; Hersch SM; Hogarth P; Bouzou B; Jensen RV; Krainc D
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11023-8. PubMed ID: 16043692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice.
    Ooms M; Rietjens R; Rangarajan JR; Vunckx K; Valdeolivas S; Maes F; Himmelreich U; Fernandez-Ruiz J; Bormans G; Van Laere K; Casteels C
    Neurobiol Aging; 2014 Dec; 35(12):2858-2869. PubMed ID: 25018107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal metabolite changes in Huntington's disease during disease onset.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; van Buchem MA; Roos RA; van der Grond J
    J Huntingtons Dis; 2014; 3(4):377-86. PubMed ID: 25575959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delineation of a 50 kilobase DNA segment containing the recombination site in a sporadic case of Huntington's disease.
    Weber B; Riess O; Wolff G; Andrew S; Collins C; Graham R; Theilmann J; Hayden MR
    Nat Genet; 1992 Nov; 2(3):216-22. PubMed ID: 1345172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Huntington's disease, case report.
    Ivkosic A; Titlic M; Tadic T; Erceg I; Marovic A; Primorac D
    Neurol Neurochir Pol; 2003; 37(1):235-41. PubMed ID: 12910844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.
    Peña-Sánchez M; Riverón-Forment G; Zaldívar-Vaillant T; Soto-Lavastida A; Borrero-Sánchez J; Lara-Fernández G; Esteban-Hernández EM; Hernández-Díaz Z; González-Quevedo A; Fernández-Almirall I; Pérez-López C; Castillo-Casañas Y; Martínez-Bonne O; Cabrera-Rivero A; Valdés-Ramos L; Guerra-Badía R; Fernández-Carriera R; Menéndez-Sainz MC; González-García S
    Clin Biochem; 2015 Dec; 48(18):1258-63. PubMed ID: 26210848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease.
    Weeks RA; Piccini P; Harding AE; Brooks DJ
    Ann Neurol; 1996 Jul; 40(1):49-54. PubMed ID: 8687191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical Huntington's disease: compensatory brain responses during learning.
    Feigin A; Ghilardi MF; Huang C; Ma Y; Carbon M; Guttman M; Paulsen JS; Ghez CP; Eidelberg D
    Ann Neurol; 2006 Jan; 59(1):53-9. PubMed ID: 16261565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brain.
    Gulyás B; Sovago J; Gomez-Mancilla B; Jia Z; Szigeti C; Gulya K; Schumacher M; Maguire RP; Gasparini F; Halldin C
    Brain Struct Funct; 2015 Sep; 220(5):3043-51. PubMed ID: 24969128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of the Huntington's disease (IT15) protein product in HD patients.
    Schilling G; Sharp AH; Loev SJ; Wagster MV; Li SH; Stine OC; Ross CA
    Hum Mol Genet; 1995 Aug; 4(8):1365-71. PubMed ID: 7581375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.
    Leenders KL; Frackowiak RS; Quinn N; Marsden CD
    Mov Disord; 1986; 1(1):69-77. PubMed ID: 2973559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prenatal exclusion testing for Huntington's disease: a problem of too much information.
    Millan FA; Curtis A; Mennie M; Holloway S; Boxer M; Faed MJ; Crawford JW; Liston WA; Brock DJ
    J Med Genet; 1989 Feb; 26(2):83-5. PubMed ID: 2563777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.